Sarah Premji, MD

Sarah Premji, MD, of Sarah Cannon Research Institute, discusses community trial access, biomarker-driven drug development, and key breast cancer studies to watch.

Discover key advancements in breast cancer treatment and the ongoing challenges in access, drug resistance, and patient quality of life.

Discover groundbreaking advancements in breast cancer treatment, focusing on targeted therapies, immunotherapy, and personalized care strategies for improved patient outcomes.

Sarah Premji, MD, discusses recent advancements in the breast cancer treatment landscape.

Dr Sarah Premji discusses advancements in breast cancer treatment, emphasizing community trials, personalized therapies, and how to address unmet patient needs.